The Simplistic Investor
Latest Articles
Knight Therapeutics: The Outsider CEO You've Never Heard Of
American Addiction Centers: Why It Pays To Do Your Due Diligence
Ackroo: How A Busted Unicorn Is On The Verge Of Multi-Bagger Status
Horsehead Holding: The Phones Are Ringing, And Buyers Are Calling
Tesla Starts Using Its Own Currency
Alere: Why The Recent Criminal Fraud Probe Can Doom The Company
IBM: A Hodgepodge Going Nowhere
Netflix: Don't Get Your Hopes Up
Yum Brands: Be Careful With The Spin-Off
CSX: Which Way Is This Train Going?
Herbalife: What Everyone Is Missing
Envision Healthcare And Amsurg: How The Combination Affects Shareholders
Oracle: NetSuite Acquisition Rumors Heating Up
Team Health: 50% Upside For This Unsexy Industry Leader
TJX: Maybe Retail Isn't Dead?
American Airlines: Run While You Can
Berkshire Hathaway: Does Buffett Really Want Yahoo?
Nordstrom: Not So Fast Amazon
Amazon: Winner Of The Blocked Staples/Office Depot Merger?
Ferro: Highly Probable Buyout Should Result In 35-65% Near-Term Upside And Limited Downside
LendingClub: The Fraud Is Just Getting Started
Don't Buy Disney... Yet
SolarCity: Musk Can't Save This One
Chipotle: E. Coli Outbreak Overshadows The Company's Hidden Gem
GoPro: Have Things Begun To Turn Around After Earnings?
Does Q1 Earnings Make Einhorn Right On Yelp?
Coca-Cola: Why The Sugar Rush Is Here To Stay
Abbott Labs: Can It Handle Both Deals?
SAExploration: Looks Like A Tempting Short, But May Triple First
Alere: Is The Deal Still On?
Surgical Care Affiliates: Best In Its Class, But Not Worth The Price
Amsurg: When The Core Business Isn't So Core